Alnylam Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ALNY Nasdaq 2830 www.alnylam.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alnylam Pharmaceuticals, Inc.

Alnylam's Latest Data Strengthen Outlook for Nucresiran, TRITON-CM, Oppenheimer Says - Aug 31st, 2026 9:40 am
Inceptive CEO Jakob Uszkoreit on Designing Medicines That Work Like Life Itself - Aug 31st, 2026 6:48 am
Alnylam Presents New Data at ESC Congress 2026 Reinforcing Strength in RNAi-Powered TTR Silencing Across ATTR-CM Patient Populations and Treatment Settings - Aug 30th, 2026 6:23 am
IONS, AZN Stocks Fall On Full Data From Failed Cardiomyopathy Trial — Jefferies Sees Neutral To Negative Readthrough To ALNY - Aug 28th, 2026 3:18 pm
Alnylam stock drops on rival heart trial: Why analysts see core business safe - Aug 28th, 2026 6:54 am
AstraZeneca, Ionis data spark debate about RNA drugs’ impact on deadly heart disease - Aug 28th, 2026 4:58 am
Moderna Stock Carries A Market Value Its Revenue Does Not Support - Aug 26th, 2026 9:13 am
BridgeBio Q2 Sales Jump 120% as Attruby Drives Commercial Momentum - Aug 25th, 2026 11:36 am
Is BBIO a Buy as Fast Sales Growth Meets a Steep Valuation Premium? - Aug 25th, 2026 11:34 am
Why BBIO Rose 24% in Three Months and Whether the Rally Can Continue - Aug 25th, 2026 11:32 am
Alnylam Pharmaceuticals (ALNY) Stock Looks Cheap After A 47% Fall Yet Rich On Earnings - Aug 25th, 2026 12:15 am
Alnylam Pharmaceuticals (ALNY) Heads To ESC With New Data, Is It A Bargain? - Aug 24th, 2026 3:10 pm
Is Alnylam (ALNY) Turning Expanded HELIOS-B and Zilebesiran Data Into Durable Cardiovascular Leadership? - Aug 24th, 2026 1:09 pm
Moderna Stock Had A Readout Waiting In Plain Sight - Aug 24th, 2026 1:01 pm
Alnylam to Present New Data Reinforcing Strength in RNAi-Powered TTR Silencing and Continued Progress in Hypertension at ESC Congress 2026 - Aug 24th, 2026 6:33 am
Moderna's Melanoma Result Landed On A Market Positioned The Other Way - Aug 20th, 2026 12:21 pm
Brixton Biosciences Strengthens Board with Industry Veterans as Company Advances Towards Commercialization of Reneurx™ Nerve-Selective Therapy for Pain Associated with Knee Osteoarthritis - Aug 18th, 2026 5:30 am
Why the Alnylam Sell-Off Looks Overdone -- and What Investors Are Missing - Aug 16th, 2026 4:01 am
Raymond James Is Betting Big on These 2 ‘Strong Buy’ Stocks - Aug 11th, 2026 11:55 am